These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29227185)

  • 1. Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine Model.
    Waterbury LD
    J Ocul Pharmacol Ther; 2018; 34(1-2):154-160. PubMed ID: 29227185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studies.
    Hovanesian JA; Sheppard JD; Trattler WB; Gayton JL; Malhotra RP; Schaaf DT; Ng E; Dunn SH
    J Cataract Refract Surg; 2015 Oct; 41(10):2060-8. PubMed ID: 26703280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
    Bucci FA; Waterbury LD
    Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
    Bucci FA; Waterbury LD
    Adv Ther; 2011 Dec; 28(12):1089-95. PubMed ID: 22105509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
    Bucci FA; Waterbury LD
    J Cataract Refract Surg; 2008 Sep; 34(9):1509-12. PubMed ID: 18721711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
    Heier JS; Awh CC; Busbee BG; Waterbury LD; Daniel P; Stoller GL; Cleary TS
    Retina; 2009 Oct; 29(9):1310-3. PubMed ID: 19934822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW; Chung BH; Kim EK; Seo KY; Kim TI
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery.
    Visco DM; Bedi R
    J Cataract Refract Surg; 2020 Jun; 46(6):867-872. PubMed ID: 32541407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery.
    Jones BM; Neville MW
    Ann Pharmacother; 2013 Jun; 47(6):892-6. PubMed ID: 23715071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical ketorolac tromethamine 0.5% versus diclofenac sodium 0.1% to inhibit miosis during cataract surgery.
    Srinivasan R; Madhavaranga
    J Cataract Refract Surg; 2002 Mar; 28(3):517-20. PubMed ID: 11973101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketorolac 0.45% ophthalmic solution.
    McCormack PL
    Drugs Aging; 2011 Jul; 28(7):583-9. PubMed ID: 21721602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Alternative to Topical Dosing to Deliver Drugs to Target Tissues.
    Waterbury LD
    J Ocul Pharmacol Ther; 2017; 33(1):3-4. PubMed ID: 27923107
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of phenylephrine/ketorolac on iris fixation ring use and surgical times in patients at risk of intraoperative miosis.
    Visco D
    Clin Ophthalmol; 2018; 12():301-305. PubMed ID: 29440873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E
    Acar U; Acar DE; Tanriverdi C; Acar M; Ozdemir O; Erikci A; Ornek F
    Ocul Immunol Inflamm; 2017 Jun; 25(3):323-327. PubMed ID: 26765265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgery.
    Donnenfeld ED; Whitaker JS; Jackson MA; Wittpenn J
    J Cataract Refract Surg; 2017 May; 43(5):597-605. PubMed ID: 28602319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
    Bucci FA; Waterbury LD
    Curr Med Res Opin; 2011 Dec; 27(12):2235-9. PubMed ID: 21992076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery.
    Gower EW; Lindsley K; Tulenko SE; Nanji AA; Leyngold I; McDonnell PJ
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006364. PubMed ID: 28192644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery.
    Price MO; Price FW
    Curr Med Res Opin; 2004 Dec; 20(12):2015-9. PubMed ID: 15701218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration.
    Katsev DA; Katsev CC; Pinnow J; Lockhart CM
    Clin Ophthalmol; 2017; 11():1897-1901. PubMed ID: 29123376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intracameral phenylephrine-ketorolac irrigation for miosis prevention in femtosecond laser-assisted cataract surgery: Reduction in surgical time and iris manipulation.
    Walter K; Delwadia N; Coben J
    J Cataract Refract Surg; 2019 Apr; 45(4):465-469. PubMed ID: 30661968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.